All News
Plazomicin: A new hope in India’s battle against AMR
Dr Harshad Limaye, Consultant – Infectious Diseases, Department of Internal Medicine, Nanavati Max Super Speciality Hospital, highlights the effectiveness of Plazomicin against AMR
Read MoreOpinion: STAT+: Recursion CEO: Biotech’s rainy season is not over — but we must race ahead
After layoffs at Recursion, the company’s CEO writes about taking inspiration from an unexpected source: “The Art of Racing in the Rain.
Read MoreSTAT+: A vaccine expert explains why she’s ‘very worried’ about RFK Jr. and new CDC vaccine advisers
A conversation with Kathryn Edwards, a physician and expert in childhood respiratory diseases and vaccine safety, on RFK Jr.'s latest ACIP shakeup.
Read MoreSTAT+: Feds greenlight $9 billion in supplemental Medicaid funds as GOP weighs new limits
States are securing billions in extra Medicaid funding before Congress caps future deals.
Read MoreOpinion: STAT+: Don’t cut NIH and NSF budgets — let the government invest like a venture capitalist
Cutting science to fix the deficit is like burning your seed corn because you’re low on groceries. It’s fiscally shortsighted and strategically self-defeating.
Read MoreOpinion: The AMA is not properly representing physicians
Billing codes are just one way the American Medical Association has strayed from its core mission.
Read MoreBlood cancer patients in England first in world to be offered ‘Trojan horse’ drug
Pioneering drug can halt advance of multiple myeloma for three times as long as standard treatmentsThousands of patients in England with blood cancer will become the first in the world to be offered a
Read MoreHow does air pollution affect mental health? New study aimed to find out
Research looked at records of 14,800 people in Bradford to see what happened after they moved to more polluted areaWhat happens to your mental and physical health when you move to an area with worse a
Read MoreAbbott and Medtronic best-positioned manufacturers in US neurology market: GlobalData
GlobalData’s report reveals that 96 per cent and 57.
Read MoreFDA clears Moderna’s RSV vaccine for use in people aged 18 to 59
The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.
Read More